Yawen Xu Selected Research

Yawen Xu Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 05/2012
9	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 10/2012
3	Infections 01/2023 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
3	Neoplasm Metastasis (Metastasis) 03/2017 - 05/2012
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 05/2012
2	Infarction (Infarctions) 01/2023 - 01/2021
2	Disease Progression 01/2022 - 01/2022
2	Leukemia 01/2020 - 01/2017
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2018 - 10/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2017 - 02/2012
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Breast Cancer Lymphedema 01/2024
1	Cognitive Dysfunction 10/2023
1	Thrombosis (Thrombus) 01/2023
1	COVID-19 01/2023
1	Breakthrough Infections 01/2023
1	Cholangiocarcinoma 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Cerebral Infarction 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Macrophage Activation Syndrome 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2020
1	Acute Promyelocytic Leukemia 01/2020
1	Insulin Resistance 11/2019
1	Type 2 Diabetes Mellitus (MODY) 02/2019
1	Hyperplasia 01/2018
1	Urinary Retention 01/2018
1	Carcinogenesis 01/2016
1	Urinary Calculi (Urinary Calculus) 11/2013
1	Hemorrhage 10/2013
1	Pathologic Constriction (Stenosis) 03/2013

Drug/Important Bio-Agent (IBA)

4	Docetaxel (Taxotere)FDA Link 03/2023 - 10/2012
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2013
3	lenvatinibIBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 03/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2018
2	lycorineIBA 03/2017 - 01/2017
2	AlkaloidsIBA 03/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 03/2017 - 05/2012
2	Small Interfering RNA (siRNA)IBA 11/2015 - 01/2013
1	hydroxide ionIBA 10/2023
1	CateninsIBA 03/2023
1	Long Noncoding RNAIBA 03/2023
1	HomocysteineIBA 01/2023
1	VaccinesIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	camrelizumabIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	sintilimabIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	3-iodo-4-azido-N-hexadecylsalicylamideIBA 01/2021
1	Corn Oil (Oil, Corn)IBA 01/2021
1	benzimidazoleIBA 01/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	triphenylphosphoniumIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Growth InhibitorsIBA 03/2017
1	LuciferinsIBA 03/2017
1	Immune Checkpoint InhibitorsIBA 03/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	napabucasinIBA 01/2016
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2016
1	MethyltransferasesIBA 11/2015
1	DNA Methyltransferase 3BIBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2013
1	Androgen Receptors (Androgen Receptor)IBA 10/2012
1	AndrogensIBA 10/2012

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2016
2	Aftercare (After-Treatment) 01/2022 - 01/2021
1	Moxibustion 01/2024
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 01/2019
1	Eye Enucleation (Enucleation, Eye) 07/2018
1	Transurethral Resection of Prostate (TURP) 01/2018
1	Ligation 03/2017
1	Castration 01/2016
1	Radiotherapy 03/2015
1	Local Anesthesia 11/2013
1	Percutaneous Nephrolithotomy 11/2013
1	Semiconductor Lasers 10/2013
1	Catheters 10/2013
1	Stents 03/2013
1	Replantation 03/2013